Biotechnology News

October 20, 2014

PROVIDENCE, R.I.--(BUSINESS WIRE)--Tech Collective Tech10 Awards program honors ten Rhode Island IT practitioners, digital media designers, and entrepreneurs; to be recognized at celebration event on Nov. 20

October 20, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences will hold its third-quarter earnings call on Monday, Oct. 27 at 10 a.m. ET.

October 20, 2014

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, today announced that it intends to offer and sell common stock and warrants in an underwritten public offering. The offering is subject to market...

October 20, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina reports record financial results for third quarter of fiscal year 2014. The company substantially raises fiscal year 2014 guidance.

October 20, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced the SureSelect Focused Exome, a target enrichment solution that enables deep coverage of only those target regions that have been associated with disease....

October 20, 2014

BOULDER, Colo.--(BUSINESS WIRE)--SomaLogic, Inc., announced today that Novartis has extended its multi-year research agreement for the development and application of SomaLogic’s unique proteomics technology to Novartis’ drug discovery and...

October 20, 2014

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS Wins Large Regional Tender in Middle East

October 20, 2014

NASHVILLE, Tenn.--(BUSINESS WIRE)--PointClickCare announced enrollment is available for its secure Integrated Direct Messaging tool, which provides efficient and effective communication between senior care providers and their partners.

October 20, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News : ERYTECH (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

October 20, 2014

LOS ANGELES--(BUSINESS WIRE)--In a first step toward future human therapies, researchers at The Saban Research Institute of Children’s Hospital Los Angeles have shown that esophageal tissue can be grown in vivo from both human and mouse cells....

October 20, 2014

BOSTON--(BUSINESS WIRE)--Today IBC Life Sciences, is pleased to kick off the 2014 edition of BioProcess International Conference & Exhibition, the world’s largest event dedicated to biological development and manufacturing.

October 20, 2014

EVRY, France--(BUSINESS WIRE)--Regulatory News: Global Bioenergies (Paris:ALGBE) (Alternext Paris: ALGBE), the industrial biology company that develops sustainable routes to light olefins, today publishes audited financial statements for the six...

October 20, 2014

MALVERN, Pa.--(BUSINESS WIRE)--Phlexglobal, the specialist provider of innovative Trial Master File (TMF) and electronic Trial Master File (eTMF) expertise, solutions and services to the life sciences industry, announces a key appointment to its...

October 20, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company, announced today that the Food and Drug Administration (FDA) has approved the inclusion of efficacy and safety data from the TOWER and TOPIC studies of once-daily, oral Aubagio® (...

October 20, 2014

HALIFAX, Nova Scotia--(BUSINESS WIRE)--The opening reception for BioPort Atlantic 2014, where Atlantic Canada’s leaders in life sciences meet, kicks off today. The full conference agenda unfolds tomorrow, October 21, 2014, at the World Trade and...

October 20, 2014

OKLAHOMA CITY--(BUSINESS WIRE)--Optim Oncology, a practice in The US Oncology Network and a leader in providing quality oncology care throughout Oklahoma, announced today it has expanded its practice.

October 20, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gen9, Inc., a pioneer in synthetic biology and leader in the development of scalable technologies for synthesizing and assembling DNA, today announced the appointment of Leda Notchey as Vice President of...

October 20, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced the appointment of LeRoux Jooste to the newly created position of Senior Vice President of...

October 20, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Humacyte, a pioneer in regenerative medicine, today announced it will join U.S. Secretary of Commerce Penny Pritzker on a Development Mission to Japan and South Korea later this month.

October 20, 2014

DENVER--(BUSINESS WIRE)--The Colorado BioScience Association will honor outstanding bioscience companies and individuals throughout the state at its Annual Awards Dinner, November 6, at the Denver Marriott City Center.

October 20, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter announced the launch and first shipments of HYQVIA, Baxter’s subcutaneous immunoglobulin treatment for adult patients with primary immunodeficiency (PI) in the United States.

October 20, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics today announced that the Company's CEO has been invited to present at the Cleveland Clinic’s 12th Annual Medical Innovation Summit, taking place October 26-29, 2014, in Cleveland.

October 20, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus submits clinical protocol to FDA for INTERCEPT treatment of Ebola convalescent plasma under a Compassionate Use IDE.

October 20, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--SciQuest, Inc. (NASDAQ: SQI), a leading provider of cloud-based business automation solutions for spend management, today announced the latest charitable contributions from its SciQuest Charitable Fund. The...

October 20, 2014

SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics Launches Patient Mobile App at ASHG 2014

October 20, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today the presentation of initial data from a Phase IIa clinical study in functional dyspepsia with IW-9179, an investigational guanylate cyclase-C (GC-C)...

October 20, 2014

BILLERICA, Mass. & HUNTSVILLE, Ala.--(BUSINESS WIRE)--HudsonAlpha Institute for Biotechnology named latest RainDance Center of Excellence; Biotech research center adopts complete RainDance product portfolio to enhance next-generation...

October 20, 2014

SAN JOSE, Calif.--(BUSINESS WIRE)--The new Thermo Scientific Q Exactive Focus LC-MS/MS makes the quantitative and qualitative power of Orbitrap mass spectrometry accessible to applied and small scale research laboratories.

October 20, 2014

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that RAV Gelderland-Midden in the Netherlands has equipped its fleet of 20 ambulances with the ZOLL...

October 20, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that the Barnes-Jewish Hospital at Washington University Medical Center in St. Louis, MO, is the fourth clinical site in the company’s on-going IDE pilot...

October 20, 2014

BILLERICA, Mass. & SAN DIEGO--(BUSINESS WIRE)--RainDance Technologies Showcases Novel Sequencing Solutions at 2014 American Society of Human Genetics Annual Meeting With Leading Genomic Researchers from Baylor and Cincinnati Children's...

October 20, 2014

MENLO PARK, Calif. & SYDNEY--(BUSINESS WIRE)--Personalis and the Garvan Institute announced a partnership to deliver high-quality, large-scale human whole genome sequencing, analysis and interpretation for researchers and clinicians,...

October 20, 2014

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that results from a double-blind, placebo-controlled, multicenter phase II trial of GED-0301 in 166...

October 20, 2014

MENLO PARK, Calif. & SAN DIEGO--(BUSINESS WIRE)--Personalis, Inc. is launching an expanded portfolio of cancer research solutions based on its ACE (Accuracy and Content Enhanced) sequencing, informatics and content technology platform at ASHG...

October 20, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist announced that its Board of Directors has selected Robert J. Perez as the Company’s next Chief Executive Officer, effective January 1, 2015, succeeding current CEO Michael W. Bonney.

October 20, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix announces exclusively licensed technology from Peptide Groove LLP to enable HLA typing of human samples from genotyping data for a broad range of HLA typing application needs.

October 20, 2014

PORTLAND, Ore.--(BUSINESS WIRE)--AgonOx’s OX40 Platform Being Utilized in MedImmune’s Phase 1 OX40 Agonist Study

October 20, 2014

LEIDEN, Netherlands--(BUSINESS WIRE)--BBB Therapeutics Appoints Jan van Heek as Chairman of the Supervisory Board

October 20, 2014

LONDON--(BUSINESS WIRE)--Mucosis B.V., a clinical stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious diseases, will present research on its lead intranasal...

October 20, 2014

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ: 4573): We are pleased to announce that as of today, the company has started the phase one clinical trial for the new molecular entity RTU-1096, which is a vascular adhesion protein-1 (VAP-1) inhibitor...

October 20, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Reference is made to the stock exchange announcement made by Diagenic ASA (OSE:DIAG) on 17 October 2014 regarding the change of company name. The change has now been registered with the Register of...

October 20, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Reference is made to the stock exchange announcement by Diagenic ASA (the "Company" or "Diagenic")(OSE:DIAG) on 9 October 2014 regarding the minutes from the extraordinary general meeting and...

October 20, 2014 (All day)

PASADENA, Calif.--(BUSINESS WIRE)--Genervon Announces ALS and PD Phase 2a Trial Results. Both clinical and biomarker data suggested that a six-dose treatment of GM6 begins the disease modification with statistically significance.

October 19, 2014

TOKYO & GAITHERSBURG, Md.--(BUSINESS WIRE)--Hitachi High-Technologies Corporation and OpGen, Inc., a leading genetic analysis company, today announced the introduction of an Early Access Program for its upcoming Human Chromosome ExplorerSM,...

October 19, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Lab7 Systems announces the release of the Lab7 ESP, the first comprehensive enterprise software for genomic sequencing laboratories.

October 18, 2014

DUBLIN, Calif. & CHICAGO--(BUSINESS WIRE)--Quality and efficiency right from the start: with the Essential Line, ZEISS offers its customers an expanded diagnostic portfolio

October 17, 2014

MILWAUKEE--(BUSINESS WIRE)--Shaking off old paradigms and embracing the innovations of smaller, emerging life science companies will be the focus of Dohmen Life Science Services inaugural Entrepreneur Summit, Oct. 21-22.

October 17, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that the United States Food and Drug Administration (FDA) has approved an updated label for EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release (ER) capsules,...

October 17, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its third quarter earnings results after market close on Thursday, October 30, 2014. Management will hold a conference call to...